Literature DB >> 31692050

Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.

Dongli Zhao1, Chune Ren2, Yan Yao1, Qinjian Wang1, Fei Li1, Yang Li1, Aifang Jiang2, Guili Wang2.   

Abstract

PURPOSE: Endometrial carcinoma (EC), a common gynecological malignancy with high incidence, affects the mental and physical health of women. Mounting evidence shows that long noncoding RNAs (lncRNAs), messenger RNAs (mRNAs), and microRNAs (miRNAs) have instrumental roles in various biological processes associated with the pathogenesis of EC. In this research, we intend to further study the mechanism of EC and the potential predictive markers of EC.
METHODS: First, we obtained original data of EC RNA transcripts from The Cancer Genome Atlas database and performed differential analysis. Subsequently, according to the miRcode online software, relationship pairs of lncRNA-miRNA were constructed, and miRNA-mRNA pairs were established based on miRDB, TargetScan, and miRTarBase. Then, we constructed the competing endogenous RNA (ceRNA) network based on lncRNA-miRNA and miRNA-mRNA pairs. To further explain the function of the ceRNA network and explore the potential prognostic markers, functional enrichment analysis, and survival analysis were carried out.
RESULTS: The research showed that there were 744 differential expression lncRNAs (DElncRNAs), 164 differential expression miRNAs (DEmiRNAs), and 2447 differential expression mRNAs (DEmRNAs) between EC tissues and normal tissues. Subsequently, we built 103 DEmiRNA-DEmRNA interaction pairs and 369 DElncRNA-DEmiRNA pairs. Then, we established the ceRNA network of EC, including 62 DElncRNAs, 26 DEmiRNAs, and 70 DEmRNAs. Moreover, 10 of 62 lncRNAs, 19 of 70 mRNAs, and 4 of 26 miRNAs that closely related to the survival of EC with P < .05 were obtained. Notably, based on this network, it was found that LINC00261-hsa-mir-31 pair and LINC00261-hsa-mir-211 target pairs could be used as the potential prognostic markers of EC.
CONCLUSION: This research recommended an available basis for the molecular mechanism of EC and prognosis prediction, which could help guide the subsequent treatments and predict the prognosis for patients with EC.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  The Cancer Genome Atlas database; competing endogenous RNA network; endometrial carcinoma; lncRNA; mRNA; miRNA; prognosis

Mesh:

Substances:

Year:  2019        PMID: 31692050     DOI: 10.1002/jcb.29466

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Box C/D snoRNA SNORD89 influences the occurrence and development of endometrial cancer through 2'-O-methylation modification of Bim.

Authors:  Hai-Juan Bao; Xi Chen; Xin Liu; Wu Wu; Qian-Hui Li; Jing-Yuan Xian; Yang Zhao; Shuo Chen
Journal:  Cell Death Discov       Date:  2022-07-05

Review 2.  Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review.

Authors:  Gloria Ravegnini; Francesca Gorini; Eugenia De Crescenzo; Antonio De Leo; Dario De Biase; Marco Di Stanislao; Patrizia Hrelia; Sabrina Angelini; Pierandrea De Iaco; Anna Myriam Perrone
Journal:  Int J Cancer       Date:  2021-11-17       Impact factor: 7.316

3.  Identification of Functional lncRNAs Associated With Ovarian Endometriosis Based on a ceRNA Network.

Authors:  Jian Bai; Bo Wang; Tian Wang; Wu Ren
Journal:  Front Genet       Date:  2021-01-27       Impact factor: 4.599

4.  LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity.

Authors:  Agnes Dorn; Markus Glaß; Carolin T Neu; Beate Heydel; Stefan Hüttelmaier; Tony Gutschner; Monika Haemmerle
Journal:  Cancers (Basel)       Date:  2020-05-13       Impact factor: 6.639

Review 5.  MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review.

Authors:  Amélia Favier; Grégoire Rocher; Annette K Larsen; Romain Delangle; Catherine Uzan; Michèle Sabbah; Mathieu Castela; Alex Duval; Céline Mehats; Geoffroy Canlorbe
Journal:  Cancers (Basel)       Date:  2021-03-06       Impact factor: 6.639

Review 6.  Endometrial cancer-is our knowledge changing?

Authors:  Milena Králíčková; Vaclav Vetvicka; Antonio Simone Laganà
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.